1. Home
  2. TWIN vs CCCC Comparison

TWIN vs CCCC Comparison

Compare TWIN & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twin Disc Incorporated

TWIN

Twin Disc Incorporated

HOLD

Current Price

$18.84

Market Cap

224.5M

Sector

Industrials

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.24

Market Cap

240.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWIN
CCCC
Founded
1918
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
224.5M
240.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
TWIN
CCCC
Price
$18.84
$2.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$12.00
$7.25
AVG Volume (30 Days)
34.0K
1.7M
Earning Date
02-04-2026
02-26-2026
Dividend Yield
0.83%
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$347,837,000.00
$30,108,000.00
Revenue This Year
$10.79
N/A
Revenue Next Year
$8.43
N/A
P/E Ratio
$782.37
N/A
Revenue Growth
14.24
N/A
52 Week Low
$6.16
$1.09
52 Week High
$19.33
$4.03

Technical Indicators

Market Signals
Indicator
TWIN
CCCC
Relative Strength Index (RSI) 68.79 51.91
Support Level $16.79 $2.02
Resistance Level $18.96 $2.47
Average True Range (ATR) 0.73 0.15
MACD 0.14 0.04
Stochastic Oscillator 93.29 63.33

Price Performance

Historical Comparison
TWIN
CCCC

About TWIN Twin Disc Incorporated

Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: